E-LIB Suche - Ergebnisse für: Belknap, Robert

1

Comparison of 3 optimized delivery strategies for completio..:

Semitala, Fred C. ; Kadota, Jillian L. ; Musinguzi, Allan...
PLOS Medicine. 21 (2024) 2 - p. e1004356 , 2024

Link: https://doi.org/10.1371/..

2

Using Electronic Health Record Data to Measure the Latent T..:

Vonnahme, Laura A. ; Raykin, Julia ; Jones, Matthew...
AJPM Focus. 2 (2023) 4 - p. 100148 , 2023

Link: https://doi.org/10.1016/..

3

Symptoms and Systemic Drug Reactions in Persons Receiving W..:

Sadowski, Claire ; Belknap, Robert ; Holland, David P...
Clinical Infectious Diseases. 76 (2023) 12 - p. 2090-2097 , 2023

Link: https://doi.org/10.1093/..

4

Using a medication event monitoring system to evaluate self..:

Scott, Nigel A. ; Sadowski, Claire ; Vernon, Andrew...
Contemporary Clinical Trials. 129 (2023) - p. 107173 , 2023

Link: https://doi.org/10.1016/..

5

Completion of isoniazid–rifapentine (3HP) for tuberculosis ..:

Semitala, Fred C. ; Kadota, Jillian L. ; Musinguzi, Allan...
PLOS Medicine. 18 (2021) 12 - p. e1003875 , 2021

Link: https://doi.org/10.1371/..

6

Guidelines for the treatment of latent tuberculosis infecti..:

Sterling, Timothy R. ; Njie, Gibril ; Zenner, Dominik...
American Journal of Transplantation. 20 (2020) 4 - p. 1196-1206 , 2020

Link: https://doi.org/10.1111/..

7

Protocol for the 3HP Options Trial: a hybrid type 3 impleme..:

Kadota, Jillian L. ; Musinguzi, Allan ; Nabunje, Juliet...
Implementation Science. 15 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

8

Optimal Testing Choice and Diagnostic Strategies for Latent..:

Pettit, April C ; Stout, Jason E ; Belknap, Robert...
Clinical Infectious Diseases. 73 (2020) 7 - p. e2278-e2284 , 2020

Link: https://doi.org/10.1093/..

9

Guidelines for the Treatment of Latent Tuberculosis Infecti..:

Sterling, Timothy R. ; Njie, Gibril ; Zenner, Dominik...
Morbidity and Mortality Weekly Report: Recommendations and Reports. 69 (2020) 1 - p. 1-11 , 2020

Link: https://www.jstor.org/st..

10

Clinical Characteristics of Active Tuberculosis Diagnosed A..:

Flynn, Andrew G ; Aiona, Kaylynn ; Haas, Michelle K..
Clinical Infectious Diseases. 71 (2019) 5 - p. 1320-1323 , 2019

Link: https://doi.org/10.1093/..

11

Tuberculosis screening, testing, and treatment of U.S. heal..:

Sosa, Lynn E. ; Njie, Gibril J. ; Lobato, Mark N....
American Journal of Transplantation. 19 (2019) 8 - p. 2383-2387 , 2019

Link: https://doi.org/10.1111/..

12

Tuberculosis Screening, Testing, and Treatment of U.S. Heal..:

Sosa, Lynn E. ; Njie, Gibril J. ; Lobato, Mark N....
Morbidity and Mortality Weekly Report. 68 (2019) 19 - p. 439-443 , 2019

Link: https://www.jstor.org/st..

13

Latent tuberculosis infection: Opportunities and challenges:

Chee, Cynthia B.E. ; Reves, Randall ; Zhang, Ying.
Respirology. 23 (2018) 10 - p. 893-900 , 2018

Link: https://doi.org/10.1111/..

14

Interferon-Gamma Release Assay-Based Screening for Pediatri..:

Gaensbauer, James ; Gonzales, Bryn ; Belknap, Robert..
The Journal of Pediatrics. 200 (2018) - p. 202-209 , 2018

Link: https://doi.org/10.1016/..

15

Highly Multiplexed Proteomic Analysis of Quantiferon Supern..:

De Groote, Mary Ann ; Higgins, Michael ; Hraha, Thomas...
Journal of Clinical Microbiology. 55 (2017) 2 - p. 391-402 , 2017

Link: https://doi.org/10.1128/..